Hostname: page-component-797576ffbb-xg4rj Total loading time: 0 Render date: 2023-12-03T09:15:12.209Z Has data issue: false Feature Flags: { "corePageComponentGetUserInfoFromSharedSession": true, "coreDisableEcommerce": false, "useRatesEcommerce": true } hasContentIssue false

Vaccine-Induced Myocarditis in Two Intern Doctors in the Same Night Shift

Published online by Cambridge University Press:  19 July 2022

Mustafa Emin Canakci*
Emergency Department, Eskisehir Osmangazi University, Eskisehir, Turkey
Omer Erdem Sevik
Emergency Department, Eskisehir Osmangazi University, Eskisehir, Turkey
Gokhan Dereli
Emergency Department, Eskisehir Osmangazi University, Eskisehir, Turkey
Kadir Ugur Mert
Cardiology Department, Eskisehir Osmangazi University, Eskisehir, Turkey
Nurdan Acar
Emergency Department, Eskisehir Osmangazi University, Eskisehir, Turkey
Correspondence: Mustafa Emin Canakci, MD Emergency Department Eskisehir Osmangazi University School of MedicineEskisehir, Turkey Prof. Dr. Nabi Avcı Boulevard, No:4, Meselik, Odunpazarı, 26040 E-mail:


The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people around the globe and vaccines against the disease have started to develop. Side effects of the vaccine have been reported in the literature, including myocarditis, which has a very low incidence and with a good prognosis. This case report aims to present two medical students’ vaccine-induced myocarditis cases after the first doses of BNT162b2.

These patients were young males with no previous medical history and both of them had good recovery after the disease. Both of them had their vaccine very recently before the event. These cases show that myocarditis can be seen after the first dose as well.

Global vaccination is the most effective prevention method against COVID-19. Considering the fact that morbidities after the disease occur more than the side effects of the vaccine, they are still the best option against the current pandemic.

Case Report
© The Author(s), 2022. Published by Cambridge University Press on behalf of the World Association for Disaster and Emergency Medicine

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)


Mevorach, D, Anis, E, Cedar, N, et al. Myocarditis after BNT162b2 mRNA vaccine against COVID-19 in Israel. N Engl J Med. 2021;385(23):21402149.CrossRefGoogle ScholarPubMed
Meo, SA, Bukhari, IA, Akram, J, Meo, AS, Klonoff, DC. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna vaccines. Eur Rev Med Pharmacol Sci. 2021;25(3):16631669.Google ScholarPubMed
Witberg, G, Barda, N, Hoss, S, et al. Myocarditis after COVID-19 vaccination in a large health care organization. N Engl J Med. 2021;385(23):21322139.CrossRefGoogle Scholar
Li, C, Chen, Y, Zhao, Y, et al. Intravenous injection of coronavirus disease 2019 (COVID-19) mRNA vaccine can induce acute myopericarditis in mouse model. Clin Infect Dis. 2022;74(11):19331950.CrossRefGoogle ScholarPubMed
Ling, RR, Ramanathan, K, Tan, FL, et al. Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis. Lancet Respir Med. 2022;10(7):679688.CrossRefGoogle ScholarPubMed